Highline doctor co-authors study on effective arthritis drug
Approximately 43 million Americans suffer from arthritis and that number is expected to climb higher as our population ages.
By 2020, it is estimated that 60 million people will have arthritis due to the increased number of people over 65 years of age. But relief may soon be on the way thanks to research conducted by Highline Medical Center rheumatologist Dr. Barry Bockow who has co-authored a study exploring the effectiveness of a medication intended to help with osteoarthritis of the hip.
Dr. Bockow has been on the staff at Highline as a rheumatologist for 31 years and is also a clinical associate professor of medicine at the University of Washington. He is a fellow of the American College of Physicians and been a principal investigator in more than 100 clinical studies.
Dr. Bockow, along with other physicians worldwide, enrolled a total of 313 participants to determine the effects of the medication called hylan G-F 20. Hylan G-F 20 is made from hyaluronan, a substance occurring naturally in the joints that helps with lubrication and shock absorption.